Frost & Sullivan granted the award to Barco because of VOXAR 3D's cost-effective deployment options, which provide unlimited access to advanced visualization toolsets and clinical application modules everywhere users need them throughout the hospital.

"Thanks to the sure-fire combination of value and user-friendliness, the VOXAR 3D software can be seamlessly and affordably integrated into a wide range of PACS architectures," says Martin Bryant, Team Leader, Medical Imaging, Healthcare (EMEA), Frost & Sullivan. "With Voxar 3D, there is no need to transfer image studies to a separate 3D workstation. This capability has brought tremendous workflow advantages to many hospitals, which has enhanced the reputation and acceptability of advanced visualization solutions within the medical community."

Frost & Sullivan also recognized the intrinsic customer value of the VOXAR 3D product features. Next to the immense benefit of a smooth PACS integration, which provides a seamless environment for the visualization of CT, MR and PET studies, VOXAR 3D has established itself through a dedicated response to end-user demands in terms of functionality. Thanks to the ease-of-use and intuitive operation of VOXAR 3D, users are much more productive when viewing and reading large cross-sectional image studies.

In addition, Barco received the Customer Value Award because it has extended the value of its VOXAR 3D software with the introduction of specific clinical applications. In 2005, Barco received FDA 510(k) clearance from the U.S. Food and Drug Administration for two innovative additions to the VOXAR 3D product line. VOXAR 3D VESSELMETRIX was approved for quantitative vessel analysis of CT and MR angiographic studies; VOXAR COLONSCREEN was approved for reading CT colonography studies of symptomatic and asymptomatic patients. These FDA approved clinical application modules add greater value to the VOXAR 3D product line by providing dedicated, clinical-focused tools for specific imaging applications.

«« OLYMPIA Phase I Registry Demonstrates Efficacy Of TAXUS(R) Liberte(TM) Stent System In Complex Patients And Lesions


Siemens supports the founding of the first »»


Latest Articles

<P>Frost & Sullivan granted the award to Barco because of VOXAR 3D's cost-effective deployment options, which provide unlimited access to advanced visual...